- Result of AGM
- Second Admission of Shares
- Publication of Annual Report & Notice of AGM
- Supply of Products to New US Customer
- Exercise of Share Options and Total Voting Rights
- Final Results
- Fundraise, RCF Extension, Termination of CLN & TVR
- Early Economic Analysis of Feasibility Study Data
- Product Supplied to First Two Sales Contracts
- Fundraise, Update on Future CLN Financing & TVR
More ▼
Key statistics
On Friday, Celadon Pharmaceuticals PLC (CEL:LSE) closed at 75.00, 15.38% above the 52 week low of 65.00 set on Jun 19, 2024.
52-week range
Open | 75.00 |
---|---|
High | 77.00 |
Low | 77.00 |
Bid | 70.00 |
Offer | 85.00 |
Previous close | 75.00 |
Average volume | 30.73k |
---|---|
Shares outstanding | 65.98m |
Free float | 20.93m |
P/E (TTM) | -- |
Market cap | 49.49m GBP |
EPS (TTM) | -0.1154 GBP |
Data delayed at least 20 minutes, as of Jul 05 2024 15:45 BST.
More ▼
Investors Chronicle View
The last IC recommendation on Celadon Pharmaceuticals PLC shares was Hold at 164.00 on 05 Jun 2023Read the full article